The collaboration is part of VitaDAO’s latest fundraising disclosed in late January from strategic members, including Pfizer Ventures, Shine Capital and L1 Digital — among other longevity enthusiasts. The $4.1 million raised will fund longevity research projects and accelerate the spinout of VitaDAO’s first biotech startups, with two more in development for 2023.
Continue Reading on Coin Telegraph
Source: Cryptocurrency - investing.com
